Revenue
2011
2012
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $38.68B | $40.90B | $44.47B | $52.27B | $34.27B | $22.20B | — | — | — | — | — | — | — | $4.36B | $4.17B | $3.65B | $3.46B | — | — |
| Research & development | $134.0M | $118.0M | $84.0M | $74.0M | $89.0M | $105.0M | $133.0M | $110.0M | $111.0M | $152.0M | $149.0M | $128.0M | $154.0M | $147.0M | $120.0M | $97.0M | $110.0M | $83.0M | — |
| Net income | $3.27B | $4.79B | $4.89B | $7.34B | $2.48B | −$1.86B | $2.20B | $2.31B | $490.0M | $2.17B | $1.12B | $3.79B | $2.83B | $3.77B | $3.37B | $2.21B | $1.58B | $3.88B | $3.19B |
| Basic EPSper diluted share | CA$6.50 | CA$9.05 | CA$8.51 | CA$11.47 | CA$3.48 | -CA$2.53 | CA$2.88 | CA$2.87 | CA$0.58 | CA$2.55 | CA$1.32 | CA$4.47 | CA$3.34 | CA$4.44 | CA$3.98 | CA$2.61 | CA$1.86 | CA$4.39 | CA$3.43 |
| Diluted EPSper diluted share | CA$6.48 | CA$9.03 | CA$8.49 | CA$11.44 | CA$3.48 | -CA$2.53 | CA$2.88 | CA$2.86 | CA$0.58 | CA$2.55 | CA$1.32 | CA$4.45 | CA$3.32 | CA$4.42 | CA$3.95 | CA$2.59 | CA$1.84 | CA$4.36 | CA$3.41 |